Form 4: CV Sciences CFO Acquires 2,350,000 Stock Options

Joerg Grasser, CFO of CV Sciences, Inc., reports the acquisition of 2,350,000 employee stock options.

Summary

• Joerg Grasser, the Chief Financial Officer of CV Sciences, Inc. (CVSI), filed a Form 4 with the SEC.
• The filing reports the acquisition of 2,350,000 employee stock options on February 18, 2025.
• The exercise price of the options is $0.0375.
• The options vest in 36 equal monthly installments starting from February 18, 2025, contingent upon continued service.
• The options expire on February 17, 2035.
• Following the transaction, Grasser directly owns 2,350,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock option grants, which doesn't inherently indicate positive or negative sentiment, but the grant itself can be seen as a positive incentive for the CFO.

Positives

• The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice for company insiders reporting transactions in their company's securities, providing transparency to the market.

Stakeholder Impact

• The granting of stock options aligns the CFO's interests with those of the shareholders, incentivizing him to increase the company's value.

Key Dates

Keywords

Form 4, CV Sciences, CVSI, stock options, Joerg Grasser, CFO, beneficial ownership, SEC filing